Key facts
- This page summarizes Erez Aminov's Form 4 filing for Telomir Pharmaceuticals, Inc. (TELO).
- 4 reported transactions and 4 derivative rows are listed below.
- Accepted by SEC: 22 May 2026, 20:00.
Erez Aminov - 21 May 2026 Form 4 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)
- Reporting relationship
- CEO and Chairman, Director
- Issuer ticker
- TELO
- Reported as of
- 21 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 May 2026, 20:00:22 UTC
- Prior SEC filing
- 24 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Erez Aminov
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Erez Aminov filed Form 4 for Telomir Pharmaceuticals, Inc. (TELO) on 22 May 2026.
Change
- Previous filing in this sequence was filed on 24 Apr 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001986112
Primary reporting owner
Aminov Erez
- Relationship
- CEO and Chairman, Director
- Address
- C/O TELOMIR PHARMACEUTICALS, INC., 100 SE 2ND ST, SUITE 200 #1009, MIAMI
- Signature
- /s/ Erez Aminov
- Signature date
- 22 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TELO
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,319,710
- Date
- 21 May 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TELO
transaction
Derivative
Incentive Stock Options (right to buy)
Award
- Transaction value
- Shares
- +1,960,170
- Change %
- Price
- Shares after
- 1,960,170
- Date
- 21 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,960,170
- Exercise price
- $1.30
- Footnotes
- F1, F2
TELO
transaction
Derivative
Incentive Stock Options (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -1,960,170
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,960,170
- Exercise price
- $5.02
- Footnotes
- F2
TELO
transaction
Derivative
Non-Qualified Stock Options (right to buy)
Award
- Transaction value
- Shares
- +2,000,000
- Change %
- Price
- Shares after
- 2,000,000
- Date
- 21 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,000,000
- Exercise price
- $1.30
- Footnotes
- F1, F2
TELO
transaction
Derivative
Non-Qualified Stock Options (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -2,000,000
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,000,000
- Exercise price
- $2.10
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The options are fully exercisable.
Footnote F2
The reporting person agreed to cancellation of options granted to him on 08/27/2024 and 05/27/2025, in exchange for new options having a lower exercise price.